Josh Cohen
Founder bei AMYLYX PHARMACEUTICALS, INC.
Vermögen: 9 Mio $ am 31.03.2024
Profil
Joshua B.
Cohen is the founder of Amylyx Pharmaceuticals, Inc., where he holds the title of Co-Chief Executive Officer & Executive Director since 2014.
He is also the founder of Brown Biotechnology Investment Group.
Mr. Cohen's current job is as a Director at Practice XYZ LLC.
Mr. Cohen's education includes an undergraduate degree from Brown University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
16.04.2024 | 3 202 852 ( 4,73% ) | 9 Mio $ | 31.03.2024 |
Aktive Positionen von Josh Cohen
Unternehmen | Position | Beginn |
---|---|---|
AMYLYX PHARMACEUTICALS, INC. | Founder | 01.01.2013 |
Practice XYZ LLC
Practice XYZ LLC Internet Software/ServicesTechnology Services Practice XYZ, Inc. offers online platform which supports to share best practice videos. It offers corporate training, professional training, e-learning, online education, simulation training and video based training. The company was founded by Paul Tzen, Emily Foote and Karl S. Okamoto in 2011 and is headquartered in Philadelphia, PA. | Director/Board Member | - |
Ehemalige bekannte Positionen von Josh Cohen
Unternehmen | Position | Ende |
---|---|---|
Brown Biotechnology Investment Group | Founder | - |
Ausbildung von Josh Cohen
Brown University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AMYLYX PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Practice XYZ LLC
Practice XYZ LLC Internet Software/ServicesTechnology Services Practice XYZ, Inc. offers online platform which supports to share best practice videos. It offers corporate training, professional training, e-learning, online education, simulation training and video based training. The company was founded by Paul Tzen, Emily Foote and Karl S. Okamoto in 2011 and is headquartered in Philadelphia, PA. | Technology Services |
Brown Biotechnology Investment Group |